Search

A recent study conducted in Mandi, India, focused on myoepithelial carcinoma of the breast, an extremely rare form of cancer. The researchers reviewed 72 cases reported in the literature to gain a better understanding of the disease and its response to different treatments. The study found that surgery with negative margins is the primary treatment for this aggressive cancer. However, the benefits of radiotherapy and chemotherapy were inconclusive, and most patients had a poor response to both. The study also reported locoregional recurrence in 25% of patients and distant metastases in 23.6% of patients. [Extracted from the article]

A study conducted by researchers at Oxford University Hospitals NHS Foundation Trust in the United Kingdom found significant variability in the perioperative management of phaeochromocytoma and paraganglioma (PPGL) in different centers. The study analyzed data from the United Kingdom Registry for Endocrine and Thyroid Surgery (UKRETS) database and surveyed UK clinicians. The findings revealed that laparoscopic surgery was the predominant method used for PPGL operations, and there was a median length of stay of 4 days. The study also highlighted the need for a consensus document to harmonize practice across the UK and improve patient outcomes. [Extracted from the article]

A new study conducted at the King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia, focuses on osteosarcomas, a primary bone malignancy in children and adolescents that often metastasizes to the lungs. The study emphasizes the importance of chest computed tomography (CT) in the early detection and monitoring of lung metastases. The researchers highlight various imaging patterns and features that radiologists should be familiar with to ensure timely diagnosis and effective management. The study provides valuable insights into the role of imaging technology in detecting and characterizing osteosarcoma metastasis. [Extracted from the article]

A recent study conducted at Indiana University aimed to understand the motivations of Latinas who have participated in a unique breast cancer clinical trial. The researchers interviewed 20 Latina women who had previously donated healthy breast tissue to a biobank as part of the trial. The findings revealed that bilingual recruitment materials and having bilingual research team personnel were important motivators for participation. Additionally, participants were motivated by the knowledge of their underrepresentation in medical research and the belief that their participation could benefit other Latinas in the future. The study suggests that targeted recruitment messaging should emphasize the consequences of underrepresentation and communicate the potential positive impact of participation on the health of Latinas. [Extracted from the article]

A recent study conducted by researchers at Massachusetts General Hospital has found that prophylactic antibiotic usage is common in breast cancer surgery. The study surveyed 295 surgeons from around the world and found that 89% of respondents reported using prophylactic antibiotics. Cephalosporins were the most preferred choice of antibiotics for prophylaxis. The study also found that academic surgeons and those specializing in breast cancer surgery were more likely to prescribe prophylactic antibiotics. These findings highlight the need for further research and guidelines to optimize antibiotic stewardship in breast cancer surgery. [Extracted from the article]

Researchers at Hebei University of Technology in Tianjin, China have developed a new breast cancer detection model based on multi-scale feature reinforcement network. The model, called Multi-scale Reinforcement Breast Mass Detection Network (MRBMDNet), utilizes deep learning-based approaches to accurately detect masses from X-ray images. The researchers incorporated the Multi-scale Reinforcement Feature Pyramid Network (MRFPN) into Faster RCNN to enhance the network's capability to detect objects of arbitrary sizes. The proposed model outperformed the baseline on various datasets, achieving high accuracy in breast cancer detection. The research was supported by the National Natural Science Foundation of China. [Extracted from the article]

A new report from researchers at Washington University discusses the treatment resistance of melanoma, a type of skin cancer. The study focused on the BRAF-MEK cascade, a therapy that has revolutionized treatment for patients with advanced melanoma. However, the research found that 80% of patients treated with this therapy will still experience progression of the disease within five years. The study used single cell RNA analysis to create an atlas of melanoma cells and identified specific genetic events associated with metastatic melanomas. The researchers also established three treatment-resistant cell lines and found that certain genes were highly expressed in these cells. The study emphasizes the importance of studying patient tumors and their derivative cell lines to understand disease progression, treatment response, and resistance. [Extracted from the article]

A recent study conducted by researchers from the University of Arizona explores the relationship between trauma and cancer, which are the leading causes of death in the United States. The researchers aimed to determine the impact of cancer on the outcomes of trauma patients. The study analyzed data from the American College of Surgeons-Trauma Quality Improvement Program, focusing on adult trauma patients and excluding those with severe head injuries and nonmelanomatous skin cancers. The research has been peer-reviewed and published in the Journal of Surgical Research. For more information, readers can contact Bellal Joseph at the University of Arizona. [Extracted from the article]

A recent study conducted by researchers at the University of Toronto examined the use of shared-care programs in complex malignant hematology (CMH) to provide patients with access to care closer to home. The study used the RE-AIM evaluation framework to analyze 10 articles describing eight shared-care experiences. The findings showed that while indicators of reach and effectiveness were reported for a majority of the programs, there was a lack of information on health system impact and quality of life studies. The study concluded that while common elements contribute to the implementation of CMH shared-care programs, a formal evaluation is still needed. [Extracted from the article]

A recent study conducted at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, aimed to improve the management of acute promyelocytic leukemia (APL). The study found that despite successful treatment regimens and high remission rates, early death remains a concern for APL patients. The low volume of APL cases limits healthcare professionals' knowledge of the disease, leading to challenges in providing proper care. To address this, the researchers developed educational resources and implemented an intervention to increase nurses' knowledge of APL. The study showed a significant increase in knowledge test scores after the intervention. This research has been peer-reviewed and can be accessed in the Clinical Journal of Oncology Nursing. [Extracted from the article]

Dr. Manel Esteller, a research professor at the Josep Carreras Leukaemia Research Institute and Chairman of Genetics at the University of Barcelona, has been recognized by Stanford University as one of the top 2% of researchers worldwide with the most impact in all areas of science. The study, conducted by Stanford's Data Center for Biomedical Sciences, Statistics, Meta-Analysis, and Innovation, evaluated over 217,000 researchers based on the citations of their discoveries, authorship, and influence on other researchers. Dr. Esteller's research focuses on epigenetics, specifically the control of gene activity, and its application in understanding human diseases, particularly cancer. His work has contributed to the development of new diagnostic biomarkers and treatment approaches. [Extracted from the article]

A recent study conducted by researchers at Apollo Hospitals in Chennai, India, has reported on a rare case of metastatic extra-skeletal mesenchymal chondrosarcoma (ESMC) of the pancreas. The study describes the case of a 30-year-old patient who underwent surgery for chondrosarcoma in the left temporal region and later developed a lesion in the pancreas. The patient underwent a distal pancreatectomy, and the histopathological examination confirmed the presence of ESMC. The researchers highlight the rarity of this case and note that patients with ESMC generally have a good prognosis following surgery. For more information, the full article can be accessed through the provided link. [Extracted from the article]

Researchers at Sichuan University in Chengdu, China have developed a new method for detecting and monitoring the efficacy of melanoma immunotherapy. The method involves engineering the membranes of newly secreted tumorous exosomes and using lanthanide luminescence signals to amplify detection. The researchers found that their strategy allowed for precise and real-time monitoring of the effectiveness of melanoma immunotherapy. The study also revealed a significant difference in PD-L1 levels between treated and untreated groups, highlighting the cumulative therapeutic effect of repeated treatments. This research has been peer-reviewed and provides valuable insights into the field of melanoma immunotherapy. [Extracted from the article]

Sherri McFarland, a cancer researcher at the University of Texas at Arlington, has been elected president of the American Society for Photobiology (ASP), a national scientific organization focused on researching the effects of light on human health and the natural world. McFarland is known for her work in developing a cancer medication that uses light to target and destroy cancer cells through photodynamic therapy. She has received grants and patents for her research in photomedicine and is dedicated to promoting the benefits of light-based therapies for cancer treatment. Her leadership is expected to contribute to the future success of the ASP. [Extracted from the article]

A recent study conducted by researchers at the University of North Carolina Chapel Hill explored the barriers and facilitators affecting participation in cancer clinical research studies for racially and ethnically diverse populations in rural North Carolina. The study found that increasing representation of minoritized racial and ethnic populations in cancer clinical research studies is a priority in the US, as underrepresentation perpetuates health inequities. The research used a mixed-method, community-engaged approach to gather data from cancer survivors, caregivers, and healthcare professionals in rural North Carolina. The study identified the lack of invitation to participate in research as the greatest barrier for cancer survivors and caregivers, while healthcare professionals cited transportation as the main barrier for patients. The study recommends engaging the community, addressing unconscious bias, decentralizing clinical trials, and providing recruitment materials in culturally responsive formats to promote participation in cancer clinical research. [Extracted from the article]

A study conducted by researchers from UCLA Health Jonsson Comprehensive Cancer Center has provided insights into testosterone recovery after androgen deprivation therapy (ADT) in men undergoing radiotherapy for prostate cancer. The study analyzed data from five major randomized controlled trials involving 1,444 patients and found that baseline testosterone, age, and the duration of ADT are significant predictors of testosterone recovery. The researchers also developed a predictive tool, called a nomogram, which allows physicians to estimate recovery times based on patient-specific characteristics. The findings have important implications for clinical practice and can help patients and doctors make informed decisions about managing side effects and improving long-term outcomes. [Extracted from the article]

A recent study conducted by researchers at Saglik Bilimleri Universitesi has found a rare complication of perianal fistula called mucinous adenocarcinoma (MA). The study highlights that it is uncommon to see perianal fistula and mucinous adenocarcinoma together. The researchers emphasize the need for close monitoring of patients with untreated perianal fistula and chronic inflammatory processes in the fistula tract, as there is a risk of developing mucinous adenocarcinoma. The underlying pathophysiology leading to malignant transformation is still unclear, and further research is needed in this area. [Extracted from the article]

A recent study published in the Indian Journal of Pathology and Microbiology provides insight into persistent Mullerian duct syndrome (PMDS), a rare form of internal male pseudohermaphroditism. PMDS is characterized by insufficient levels of Mullerian-inhibiting substance (MIS) or insensitivity of the target organ to MIS. The study reports a case of seminoma of the testis with PMDS in a 22-year-old male, highlighting the association between undescended testis and the likelihood of developing testicular tumors in PMDS. The researchers emphasize the importance of awareness and appropriate management of this rare condition to reduce complications. [Extracted from the article]

Researchers at the University of Utah have developed an interactive decision support tool (DST) to improve communication and decision-making for individuals diagnosed with ductal carcinoma in situ (DCIS), a type of breast cancer. The DST uses a disease simulation model to predict patient-specific impacts of different treatment options and communicates personalized risk predictions using icon arrays and percentages. Data collected from users of the DST showed that their awareness of treatment options increased, and their estimated risk of dying from DCIS in 10 years decreased significantly after using the tool. The majority of participants found the DST to be helpful. This research highlights the importance of effectively informing patients about their treatment options and individual risks in the decision-making process. [Extracted from the article]

A recent study conducted in Italy aimed to understand the information needs of breast cancer survivors regarding nutrition and cancer. The study found that patients were interested in learning about how nutrition could help manage therapy side effects and affect disease progression and prognosis. The majority of participants expressed a desire to receive evidence-based information from their referring physician/specialist and nutritionist/dietitian. To address these needs, the researchers conducted a digital intervention through Instagram live broadcasts and organized a workshop for healthcare providers to provide appropriate nutritional guidance and education programs. [Extracted from the article]

A recent report from researchers at Emmanuel College in Boston, Massachusetts explores the link between mutagenic processes and cancer using evolutionary theory. The study emphasizes that cancers are the result of evolutionary events, where molecular variation accumulates in tissues and tumors. The researchers highlight the importance of sequencing this molecular variation to understand the mechanisms behind mutagenesis and identify cancer drivers. The report reviews tools to determine molecular signatures and cancer drivers, and discusses potential avenues for linking these metrics. The research has been peer-reviewed and published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. [Extracted from the article]

A recent study conducted at Chulalongkorn University in Bangkok, Thailand, explored the genetic alterations in relapsed or refractory childhood cancer cases. The study used whole exome sequencing (WES) to analyze the molecular profile of four unrelated patients under the age of 18. The researchers identified six different genetic variants in the NCOR2, COL6A3, TP53, and SMAD4 genes, which were found to be associated with tumor aggressiveness. This study is the first of its kind to demonstrate genetic alterations using WES in relapsed or refractory childhood cancer cases in Thailand. [Extracted from the article]

A report from Tarbiat Modares University discusses the role of exercise during cancer. While exercise has been shown to be beneficial before and after cancer diagnosis, its impact during cancer itself is still uncertain. The research highlights three factors crucial for metastasis and tumor progression in cancer: lactate, platelets, and angiogenesis, and suggests that exercise can also stimulate these factors. The study aims to shed light on the potential appropriateness of exercise during cancer. For more information, readers can refer to the Journal of Exercise & Organ Cross Talk. [Extracted from the article]

Researchers from Brigham and Women's Hospital in Boston, Massachusetts have developed a predictive model for clinically significant prostate cancer (csPCa) using prostate MRI and patient risk factors. The model was developed and validated using a cohort of 960 men who underwent MRI and biopsy. The model identified csPCa with a high sensitivity and negative predictive value, potentially avoiding unnecessary biopsies in about 1 in 5 men with elevated PSA levels. This research provides valuable insights into the prediction and prevention of prostate cancer. [Extracted from the article]

A recent study conducted by researchers at the Medical College of Wisconsin explores the complex factors contributing to cancer disparities and the need for diverse perspectives to address these disparities. The researchers developed a 9-month curriculum to facilitate collaboration between community members and biomedical researchers, focusing on cancer disparities, communication, and understanding different perspectives. The curriculum was found to be successful in preparing participants for transdisciplinary collaboration and establishing authentic partnerships. The study highlights the importance of mentoring and developing the skills required for collaboration with individuals from different disciplines and perspectives. [Extracted from the article]

A recent study conducted by researchers at Changchun University of Chinese Medicine explores the role of the mitochondrial solute carrier (SLC) family in the development of age-related tumors. The SLC family, which is responsible for the exchange of various substances in the body, has been found to be particularly linked to the development of colon, lung, kidney, and bladder cancers. The study suggests that understanding the role of SLC25 in tumorigenesis could potentially lead to the development of targeted therapies for age-related cancers. For more information, the full research article can be accessed through the provided link. [Extracted from the article]

A recent report from the University of South Carolina highlights the ongoing decline in cancer death rates in the United States due to advancements in prevention, screening, and treatment. However, cancer survivors still face debilitating symptoms such as cachexia, cardiotoxicity, fatigue, and mucositis, which negatively impact their quality of life and mortality rates. The study suggests that physical activity may be an effective strategy to mitigate these symptoms and improve overall well-being in cancer survivors. While physical activity programs are commonly recommended for cancer survivors, further research is needed to understand the specific physiological mechanisms and optimize their benefits for different cancer populations and treatments. [Extracted from the article]

A recent study conducted by researchers at Weill Cornell Medicine in New York City has found that different isoforms of NAD+ kinase (NADK) play a role in oxidative stress resistance and metastasis in melanoma cells. The study showed that Isoform 3 of NADK is specifically upregulated in metastatic melanoma cells and is more effective in expanding the NADP(H) pools, increasing oxidative stress resistance, and promoting metastatic colonization compared to Isoform 1. The researchers also discovered that Isoform 3 is transcriptionally upregulated by oxidative stress through the action of NRF2. These findings suggest that NADK Isoform 3 could be a potential therapeutic target for metastatic melanoma. [Extracted from the article]

Researchers at the Department of Electrical and Communication Engineering in Dehradun, India have proposed a two-dimensional material-based surface plasmon resonance (SPR) sensor to detect basal cancer. The sensor consists of a BK7 prism, gold, and hafnium diselenide materials, and has been found to have high sensitivity for the diagnosis of various cancer types. The research was funded by Taif University in Saudi Arabia and has been peer-reviewed. For more information, readers can contact Rajeev Kumar at Graphic Era Deemed Be Univ in Dehra Dun, India. [Extracted from the article]

A new report from Meharry Medical College discusses the use of community advisory boards (CABs) to address cancer disparities in minority and underserved communities. The researchers interviewed members of a CAB to understand their roles, expectations, and barriers to engagement. The study found that there is a gap between the perceptions of CAB members and the expectations of the academic team, leading to barriers such as disruptions from COVID-19, competing priorities, and role ambiguity. The study suggests that building a robust CAB requires careful planning, organization, and attention, and provides recommendations for enhancing training, communication, and onboarding for new members. [Extracted from the article]

A new report from the University of Ferhat Abbas discusses the history and effectiveness of prostate cancer screening methods. The report highlights the transition from relying on the Digital Rectal Exam (DRE) to the introduction of the PSA test for proactive detection. While the European Randomized Study of Screening for Prostate Cancer (ERSPC) initially endorsed the use of DRE in combination with PSA for early detection, further analysis suggests that DRE has limited value in subsequent screening procedures. PSA testing has become the primary screening tool due to its higher sensitivity and specificity. The report concludes that DRE's role in modern prostate cancer screening practices is diminishing. [Extracted from the article]

A recent study conducted by researchers at Amrita Vishwa Vidyapeetham in Coimbatore, India, has focused on the segmentation of skin lesions in the computer-aided diagnosis of melanoma. The study proposes an advanced segmentation framework called IARS SegNet, which incorporates skip connections, residual convolutions, and a global attention mechanism to enhance the model's interpretability and accuracy in identifying clinically relevant regions, particularly the contours of skin lesions. The research found that the proposed architecture outperformed other models, such as SegNet and U-Net, in terms of segmentation capabilities. The study's findings highlight the potential of deep learning models in improving melanoma diagnosis. [Extracted from the article]

A recent report from the Department of Integrative Oncology highlights the growing recognition of cancer as a metabolic disease, in addition to a genetic one. Integrative medicine approaches aim to address metabolic imbalances associated with cancer and alleviate related symptoms. By combining genetic and metabolic perspectives, integrative oncology offers a more holistic and patient-centered approach to cancer treatment. This research provides an overview of the evidence and comprehensive strategies supporting integrative medicine in addressing cancer metabolism. [Extracted from the article]

Researchers from Tsinghua University have published a study on pancreatic ductal adenocarcinoma (PDAC), a type of cancer with limited sensitivity to conventional therapies. The study focused on the role of the intratumoral microbiota in PDAC and its impact on patient prognosis and the tumor microenvironment. The researchers found that the intratumor microbiota in PDAC tissue had lower diversity and distinct communities compared to non-tumor tissues. They also identified specific microorganisms associated with short or long survival in PDAC patients. The findings suggest that the microbiota may serve as a promising biomarker for predicting the prognosis of PDAC. [Extracted from the article]

A recent report published by researchers at Cooper University Hospital in Camden, New Jersey focuses on Ewing sarcoma, a rare form of cancer that typically occurs within the skeletal system but can also develop outside of it. The researchers highlight the case of a 36-year-old man who presented with hematemesis and was ultimately diagnosed with primary gastric Ewing sarcoma in the cardia of the stomach. This is an extremely rare occurrence, with only 13 previous reports of primary gastric Ewing sarcoma, none of which originated in the cardia. The researchers emphasize the importance of understanding how this type of sarcoma presents and is characterized in order to develop effective treatments and accurate prognoses. [Extracted from the article]

Researchers at University Hospital Cologne in Germany have compared the guidelines for testicular cancer published by the American Urological Association and the European Association of Urology. They found a high rate of agreement between the two guidelines, with some differences in the management of certain stages and types of testicular cancer. Overall, the guidelines were largely concordant. This research has been peer-reviewed and published in European Urology Focus. [Extracted from the article]

A systematic literature review conducted by researchers at Aetion Inc. examined the use of real-world data (RWD) in emulations of oncology randomized controlled trials (RCTs). The review identified thirteen studies that used various types of RWD, and found that most of these studies had a serious risk of bias. However, the emulation performance, as measured by the hazard ratio estimate, was within the 95% confidence interval of the trial estimate in the majority of the studies. The researchers concluded that tools are needed to comprehensively evaluate factors that affect emulation performance and to assess the feasibility of RCT emulation. [Extracted from the article]

A recent study conducted at Aalborg University has developed a semi-automated tool called SARBOLD-LLM that can assist researchers and engineers in conducting literature reviews more efficiently. The tool uses Scopus and OpenAI to search for relevant papers and extract information about methods used to solve specific problems. The study found that SARBOLD-LLM performed well in the field of oncology, with precision, recall, and F1-score metrics of 0.68, 0.9, and 0.77, respectively. The tool is intended to be a complement to surveys and can help users select which methods to investigate further. [Extracted from the article]